Medicine

P. Amarenco, Philippa C. Lavallée, J. Labreuche, P. Touboul

2005.9.1LANCET NEUROLOGY

DOI: 10.29819/ant.200509.0001

tlooto Summary

From a practical point of view, since there was a favourable treatment effect overall in stroke and TIA patients in HPS, it seems reasonable to treat stroke patients with a statin and total cholesterol >135 mg/dL (3.5 mmol/dL).

Abstract

Abstract is not available.

Citation format

AMARENCO, P., et al. Stroke prevention, blood cholesterol and statins. LANCET NEUROLOGY, 2005, 14 3: 96–112.